Ramani Routray
Research Subjects
Research Interests
Ramani Routray has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Aameek Singh
IBM Almaden Research Center
1 shared publication Bruno Assuncao
Celgene, Summit, NJ, USA
1 shared publicationClaire Abu-Assal
IBM Watson Health, Cambridge, MA, USA
1 shared publicationEdward Mingle
Celgene, Summit, NJ, USA
1 shared publicationHanqing Chen
IBM Watson Health, Cambridge, MA, USA
1 shared publicationKarolina Danysz
Celgene, Summit, NJ, USA
1 shared publication
Latest Publications
- Open Access
- 11 October 2019
- Published by Springer Nature in Drug Safety
- Vol. 43 (1) , 57-66
Application of Augmented Intelligence for Pharmacovigilance Case Seriousness Determination
Introduction Identification of adverse events and determination of their seriousness ensures timely detection of potential patient safety concerns. Adverse event seriousness is a key factor in defining reporting timelines and is often performed manually by pharmacovigilance experts. The dramatic increase in the volume of safety reports necessitates exploration of scalable solutions that also meet reporting timeline requirements. Objective The aim of this study was to develop an augmented intelligence methodology for automatically identifying adverse event seriousness in spontaneous, solicited, and medical literature safety reports. Deep learning models were evaluated for accuracy and/or the F1 score against a ground truth labeled by pharmacovigilance experts. Methods Using a stratified random sample of safety reports received by Celgene, we developed three neural networks for addressing identification of adverse event seriousness: (1) a binary adverse-event level seriousness classifier; (2) a classifier for determining seriousness categorization at the adverse-event level; and (3) an annotator for identifying seriousness criteria terms to provide supporting evidence at the document level. Results The seriousness classifier achieved an accuracy of 83.0% in post-marketing reports, 92.9% in solicited reports, and 86.3% in medical literature reports. F1 scores for seriousness categorization were 77.7 for death, 78.9 for hospitalization, and 75.5 for important medical events. The seriousness annotator achieved an F1 score of 89.9 in solicited reports, and 75.2 in medical literature reports. Conclusions The results of this study indicate that a neural network approach can provide an accurate and scalable solution for potentially augmenting pharmacovigilance practitioner determination of adverse event seriousness in spontaneous, solicited, and medical literature reports.
- 11 October 2019
- Published by Springer Nature in Drug Safety
- Vol. 43 (1) , 57-66
Open AccessApplication of Augmented Intelligence for Pharmacovigilance Case Seriousness Determination
Introduction Identification of adverse events and determination of their seriousness ensures timely detection of potential patient safety concerns. Adverse event seriousness is a key factor in defining reporting timelines and is often performed manually by pharmacovigilance experts. The dramatic increase in the volume of safety reports necessitates exploration of scalable solutions that also meet reporting timeline requirements. Objective The aim of this study was to develop an augmented intelligence methodology for automatically identifying adverse event seriousness in spontaneous, solicited, and medical literature safety reports. Deep learning models were evaluated for accuracy and/or the F1 score against a ground truth labeled by pharmacovigilance experts. Methods Using a stratified random sample of safety reports received by Celgene, we developed three neural networks for addressing identification of adverse event seriousness: (1) a binary adverse-event level seriousness classifier; (2) a classifier for determining seriousness categorization at the adverse-event level; and (3) an annotator for identifying seriousness criteria terms to provide supporting evidence at the document level. Results The seriousness classifier achieved an accuracy of 83.0% in post-marketing reports, 92.9% in solicited reports, and 86.3% in medical literature reports. F1 scores for seriousness categorization were 77.7 for death, 78.9 for hospitalization, and 75.5 for important medical events. The seriousness annotator achieved an F1 score of 89.9 in solicited reports, and 75.2 in medical literature reports. Conclusions The results of this study indicate that a neural network approach can provide an accurate and scalable solution for potentially augmenting pharmacovigilance practitioner determination of adverse event seriousness in spontaneous, solicited, and medical literature reports.
- Open Access
StackInsights: Cognitive Learning for Hybrid Cloud Readiness
Hybrid cloud is an integrated cloud computing environment utilizing a mix of public cloud, private cloud, and on-premise traditional IT infrastructures. Workload awareness, defined as a detailed full range understanding of each individual workload, is essential in implementing the hybrid cloud. While it is critical to perform an accurate analysis to determine which workloads are appropriate for on-premise deployment versus which workloads can be migrated to a cloud off-premise, the assessment is mainly performed by rule or policy based approaches. In this paper, we introduce StackInsights, a novel cognitive system to automatically analyze and predict the cloud readiness of workloads for an enterprise. Our system harnesses the critical metrics across the entire stack: 1) infrastructure metrics, 2) data relevance metrics, and 3) application taxonomy, to identify workloads that have characteristics of a) low sensitivity with respect to business security, criticality and compliance, and b) low response time requirements and access patterns. Since the capture of the data relevance metrics involves an intrusive and in-depth scanning of the content of storage objects, a machine learning model is applied to perform the business relevance classification by learning from the meta level metrics harnessed across stack. In contrast to traditional methods, StackInsights significantly reduces the total time for hybrid cloud readiness assessment by orders of magnitude.
Open AccessStackInsights: Cognitive Learning for Hybrid Cloud Readiness
Hybrid cloud is an integrated cloud computing environment utilizing a mix of public cloud, private cloud, and on-premise traditional IT infrastructures. Workload awareness, defined as a detailed full range understanding of each individual workload, is essential in implementing the hybrid cloud. While it is critical to perform an accurate analysis to determine which workloads are appropriate for on-premise deployment versus which workloads can be migrated to a cloud off-premise, the assessment is mainly performed by rule or policy based approaches. In this paper, we introduce StackInsights, a novel cognitive system to automatically analyze and predict the cloud readiness of workloads for an enterprise. Our system harnesses the critical metrics across the entire stack: 1) infrastructure metrics, 2) data relevance metrics, and 3) application taxonomy, to identify workloads that have characteristics of a) low sensitivity with respect to business security, criticality and compliance, and b) low response time requirements and access patterns. Since the capture of the data relevance metrics involves an intrusive and in-depth scanning of the content of storage objects, a machine learning model is applied to perform the business relevance classification by learning from the meta level metrics harnessed across stack. In contrast to traditional methods, StackInsights significantly reduces the total time for hybrid cloud readiness assessment by orders of magnitude.
- Open Access
- 1 August 2009
- Published by Association for Computing Machinery (ACM) in Proceedings of the VLDB Endowment
- Vol. 2 (2) , 1546-1549
DIADS
- 1 August 2009
- Published by Association for Computing Machinery (ACM) in Proceedings of the VLDB Endowment
- Vol. 2 (2) , 1546-1549
Open AccessDIADS